ApiFix received Humanitarian Device Exemption approval to market the MID-C Minimally Invasive Deformity Correction system to treat adolescent idiopathic scoliosis.
Ortho Regenerative Technologies entered into an agreement to evaluate a commercial product from an unnamed orthopedic company partner for use with Ortho's Ortho-R biopolymer matrix.Â
Medtronic Chief Executive Officer Omar Ishrak announced his intention to retire in the beginning of 2Q20. Geoff Martha, currently Executive Vice President of MDT's Restorative Therapies Group, will assume the newly-created role of Medtronic President in 4Q19 and succeed Ishrak as CEO next year.Â
Fuse Medical introduced the Sterizo Total Knee, with multiple stabilization options including Cruciate Retained, Ultra Congruent Anterior Stabilized and Posterior Stabilized.
DiscGenics was granted Fast Track designation from FDA for its investigational cell therapy, IDCT, under evaluation in clinical trials in the U.S. and Japan to treat pain and disability from degenerative disc disease.